One-Year Follow-Up of Advanced Hybrid Closed-Loop System in Adults with Type 1 Diabetes Previously Naive to Diabetes Technology: The Effect of Switching to a Calibration-Free Sensor-Reference-Cited by-同舟云学术

One-Year Follow-Up of Advanced Hybrid Closed-Loop System in Adults with Type 1 Diabetes Previously Naive to Diabetes Technology: The Effect of Switching to a Calibration-Free Sensor

Published:2023-08-01 Issue:8 Volume:25 Page:554-558
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Matejko Bartłomiej¹²^ORCID,Juza Anna³⁴,Kieć-Wilk Beata¹²,Cyranka Katarzyna¹²⁵^ORCID,Krzyżowska Sabina²,Cohen Ohad⁶^ORCID,Malecki Maciej T.¹²^ORCID,Klupa Tomasz¹²

Affiliation:

1. Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.

2. Department of Metabolic Diseases and Diabetology, University Hospital in Krakow, Krakow, Poland.

3. Department of Internal Medicine, Clinical Provincial Hospital of Frederic Chopin No. 1 in Rzeszów, Rzeszów, Poland.

4. Department of Internal Medicine, College of Medical Sciences, University of Rzeszów, Rzeszów, Poland.

5. Department of Psychiatry, Jagiellonian University Medical College, Krakow, Poland.

6. Medtronic, Tolochenaz, Switzerland.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0059

Reference23 articles.

1. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

2. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study

3. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case–Control Study

4. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes

5. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort;Diabetes Research and Clinical Practice;2024-10

2. Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: a single-arm multi-phase intervention study;BMC Endocrine Disorders;2024-08-30

3. Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm;Diabetes Technology & Therapeutics;2024-06-01

4. 12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric Study;Diabetes Technology & Therapeutics;2024-06-01

5. Sustained Effectiveness of an Advanced Hybrid Closed-Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study;Diabetes Care;2024-04-16